TAG:
pathology market
Creative Destruction in Anatomic Pathology
By R. Lewis Dark | From the Volume XV No. 2 – February 11, 2008 Issue
PATHOLOGISTS MAY BE FAMILIAR with the economic theory of “creative destruction.” They are aware of how “creative destruction” is at work transforming and reshaping both the anatomic pathology marketplace and the clinical lab testing marketplace. Economist Joseph Schumpeter first used the ter…
Are Feds Ready to Strike at TC/PC Arrangements?
By Robert Michel | From the Volume XIV No. 12 – August 27, 2007 Issue
CEO SUMMARY: Pathologists and laboratory directors will want to pay attention to the proposed rules published by the Centers for Medicare and Medicaid Services on July 2, 2007. The document is a grab bag of proposals and rules that would significantly curb many common ancillary services a…
Lakewood Pathology Changes Leadership
By Robert Michel | From the Volume XIV No. 10 – July 16, 2007 Issue
CEO SUMMARY: Following the arrival of a new majority owner and a capital commitment of $50 million last year, Lakewood Pathology Associates has taken additional steps to pursue growth. Lakewood plans to acquire small to mid-sized companies that are complementary to its position in the ana…
Anatomic Pathology’s Coming Revolution: Same Day Diagnoses
By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue
CEO SUMMARY: Anatomic pathology has been conducted the same way for 100 years—but no longer at the University of Miami. Pathologists there are using microwave technology to cut processing speed by 90% and improve workflow. By producing faster diagnoses, the lab can report results on 80%…
RedPath Integrated Pathology Raises $4 Million From Investors
By Robert Michel | From the Volume XIII No. 15 – November 6, 2006 Issue
IN PITTSBURGH, PENNSYLVANIA, RedPath Integrated Pathology, Inc. is in the midst of raising money for expansion. On September 25, 2006, it announced a $4 million equity financing commitment from NewSpring Capital of Philadephia, Pennsylvania. RedPath represents an in…
TC/PC: Pathology’s Barn Door Is Now Wide Open
By Robert Michel | From the Volume XIII No. 9 – July 3, 2006 Issue
CEOSUMMARY: There’s a degree of irony in the current state of affairs. When a handful of lab companies decided to hit office-based urologists and gastroenterologists with the sales tactic of a TC/PC arrangement several years ago, no one realized the consequences of teaching these high-r…
Many Trends in AP Spell Lots of Change Ahead
By Robert Michel | From the Volume XIII No. 2 – February 6, 2006 Issue
CEO SUMMARY: Every second year, THE DARK REPORT releases its list of key trends in anatomic pathology. These trends help shape an understanding about the state of the pathology profession. Our current list includes 11 identifiable trends. This is not an auspicious sign for pathologists wh…
Bi-Annual Look at Trends Reshaping Clinical Labs
By Robert Michel | From the Volume XII No. 2 – January 24, 2005 Issue
CEO SUMMARY: Among other things, we declare the end to the heyday of the independent commercial lab company which offers a broad test menu to all types of office-based physicians. In its place springs forth the specialty or niche testing laboratory. Small and focused on a specific number …
Oncology’s Potential Drives AP Lab Expansion
By Robert Michel | From the Volume XI No. 12 – August 30, 2004 Issue
CEO SUMMARY: It is no coincidence that another public company is shifting its business focus and expanding its efforts to capture cancer-related anatomic pathology specimens. Demographic trends predict a steady increase in the number of new cancer cases yearly, while new technologies are …
Of Congress and the OIG: Speedy Action Ahead?
By Robert Michel | From the Volume XI No. 11 – August 9, 2004 Issue
CEO SUMMARY: During the short life of AP laboratory condominium complexes, they have attracted the interest of both an influential Senator and the Office of the Inspector General (OIG). Last month, Senator Charles E. Grassley sent a letter to the OIG requesting that it investigate the AP …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized